Targeting the lipid membrane to prevent viral entry: the case of a C18-alkylated EGCG compound

Key Points

• Viral entry is significantly reduced using the C18-alkylated compound, affecting membrane integrity.
• The study shows a 70% reduction in viral binding with the EGCG compound across multiple trials.
• Analysis employs in vitro techniques to assess the impact of the compound on lipid membranes.
• Highlights potential for lipid-targeting strategies in developing antiviral treatments.